Susquehanna International Group’s Sana Biotechnology SANA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$548K Buy
190,400
+48,900
+35% +$193K ﹤0.01% 9421
2025
Q4
$576K Buy
141,500
+101,800
+256% +$456K ﹤0.01% 8456
2025
Q3
$141K Sell
39,700
-128,000
-76% -$463K ﹤0.01% 11328
2025
Q2
$458K Buy
167,700
+63,500
+61% +$131K ﹤0.01% 9377
2025
Q1
$175K Sell
104,200
-174,700
-63% -$488K ﹤0.01% 11081
2024
Q4
$455K Sell
278,900
-64,100
-19% -$191K ﹤0.01% 8915
2024
Q3
$1.43M Buy
343,000
+117,400
+52% +$617K ﹤0.01% 6020
2024
Q2
$1.23M Buy
225,600
+7,600
+3% +$60.6K ﹤0.01% 6089
2024
Q1
$2.18M Buy
218,000
+194,500
+828% +$1.46M ﹤0.01% 5128
2023
Q4
$95.9K Buy
23,500
+8,100
+53% +$29.8K ﹤0.01% 11364
2023
Q3
$59.6K Sell
15,400
-392,800
-96% -$2.11M ﹤0.01% 11215
2023
Q2
$2.43M Buy
+408,200
New +$2.35M ﹤0.01% 4747
2022
Q3
Sell
-10,300
Closed -$66K 13997
2022
Q2
$66K Sell
10,300
-6,200
-38% -$39.5K ﹤0.01% 11809
2022
Q1
$136K Buy
16,500
+5,200
+46% +$42K ﹤0.01% 11646
2021
Q4
$175K Buy
+11,300
New +$218K ﹤0.01% 11604

Other funds holding SANA

Susquehanna International Group's SANA Position: Q1 2026 in Review

Susquehanna International Group reduced its Sana Biotechnology (SANA) stake by 25% in Q1 2026, selling an estimated $544K and leaving 421,555 shares worth $1.21M. The position accounts for ﹤0.01% of the portfolio, ranked #7391.

Susquehanna International Group first reported a position in SANA in Q2 2021 and has held it in 20 quarters since. The position peaked at $2.28M in Q4 2025. 202 funds tracked by Wall St. Rank hold SANA as of Q1 2026.

  • Susquehanna International Group held 421,555 shares of Sana Biotechnology worth $1.21M as of Q1 2026.
  • Susquehanna International Group sold 138,195 Sana Biotechnology shares in Q1 2026, an estimated $544K.
  • Sana Biotechnology made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #7391 holding.
  • Susquehanna International Group first reported a position in Sana Biotechnology in Q2 2021 and has held it in 20 quarters since.
  • Susquehanna International Group's Sana Biotechnology position peaked at $2.28M in Q4 2025.
  • 202 funds tracked by Wall St. Rank held Sana Biotechnology as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.